journal: The International Journal of Biostatistics

Impact Factor: 1.2

Veröffentlicht seit 1. Mai 2005

The International Journal of Biostatistics

ISSN: 1557-4679

Herausgegeben von: Antoine Chambaz, Alan E. Hubbard, Mark J. van der Laan

Manuskript einreichen

Über diese Zeitschrift

Objective
The International Journal of Biostatistics (IJB) seeks to publish new biostatistical models and methods, new statistical theory, as well as original applications of statistical methods, for important practical problems arising from the biological, medical, public health, and agricultural sciences with an emphasis on semiparametric methods. Given many alternatives to publish exist within biostatistics, IJB offers a place to publish for research in biostatistics focusing on modern methods, often based on machine-learning and other data-adaptive methodologies, as well as providing a unique reading experience that compels the author to be explicit about the statistical inference problem addressed by the paper. IJB is intended that the journal cover the entire range of biostatistics, from theoretical advances to relevant and sensible translations of a practical problem into a statistical framework. Electronic publication also allows for data and software code to be appended, and opens the door for reproducible research allowing readers to easily replicate analyses described in a paper. Both original research and review articles will be warmly received, as will articles applying sound statistical methods to practical problems.

Topics

Biostatistical methods and models
Statistical theory
Biostatistics computing and applications of statistical methods for important practical problems in the biological, medical, public health, and agricultural sciences

Article formats
Research and survey articles

Information on submission process

Submit Article

Ihre Vorteile

Your benefits

Up-to-date research on biostatistics
Original methodology
Edited by the most prominent scholars in the field
Rapid online publication of contributions ahead of print

Geschichte

One issue/year, updated continuously
Content available since 2005 (Volume 1, Issue 1)
ISSN: 1557-4679

Abstracting und Indexing

The International Journal of Biostatistics ist in den folgenden Services indiziert:

Baidu Scholar
Cabells Journalytics
CNKI Scholar (China National Knowledge Infrastructure)
CNPIEC - cnpLINKer
Current Index to Statistics
Dimensions
EBSCO (relevant databases)
EBSCO Discovery Service
EconBiz
EMBASE
Genamics JournalSeek
Google Scholar
Japan Science and Technology Agency (JST)
J-Gate
Journal Citation Reports/Science Edition
JournalGuide
JournalTOCs
KESLI-NDSL (Korean National Discovery for Science Leaders)
Mathematical Reviews (MathSciNet)
Medline
MyScienceWork
Naver Academic
Naviga (Softweco)
Primo Central (ExLibris)
ProQuest (relevant databases)
Publons
PubMed
QOAM (Quality Open Access Market)
ReadCube
Reaxys
RePEc (Research Papers in Economics): IDEAS, EconPapers
Scilit
SCImago (SJR)
SCOPUS
Semantic Scholar
Sherpa/RoMEO
Summon (ProQuest)
TDNet
Text Mining
Ulrich's Periodicals Directory/ulrichsweb
WanFang Data
Web of Science - Biological Abstracts
Web of Science - BIOSIS Previews
Web of Science - Science Citation Index Expanded
WorldCat (OCLC)
X-MOL
Yewno Discover
zbMATH Open

Zusatzmaterial

Fachgebiete

Externe Links

Online Submission of Manuscripts

Band 19 Heft 2

November 2023

Öffentlich zugänglich 15. November 2023

Frontmatter

Seiten: i-ii

PDF downloaden

Part-1: SMAC 2021 Webconference

Öffentlich zugänglich 7. Dezember 2022

Statistics, philosophy, and health: the SMAC 2021 webconference

Nicolas Savy, Erica EM Moodie, Isabelle Drouet, Antoine Chambaz, Bruno Falissard, Michael R. Kosorok, Elizabeth F. Krakow, Deborah G. Mayo, Stephen Senn, Mark Van der Laan

Seiten: 261-270

Mehr PDF downloaden

Abstract

SMAC 2021 was a webconference organized in June 2021. The aim of this conference was to bring together data scientists, (bio)statisticians, philosophers, and any person interested in the questions of causality and Bayesian statistics, ranging from technical to philosophical aspects. This webconference consisted of keynote speakers and contributed speakers, and closed with a round-table organized in an unusual fashion. Indeed, organisers asked world renowned scientists to prepare two videos: a short video presenting a question of interest to them and a longer one presenting their point of view on the question. The first video served as a “teaser” for the conference and the second were presented during the conference as an introduction to the round-table. These videos and this round-table generated original scientific insights and discussion worthy of being shared with the community which we do by means of this paper.

Part-2: Regular Articles

28. Oktober 2022

“Show me the DAG!”

Elizabeth F. Krakow

Seiten: 271-272

Öffentlich zugänglich 5. September 2022

Causal inference for oncology: past developments and current challenges

Erica E. M. Moodie

Seiten: 273-281

Mehr PDF downloaden

Abstract

In this paper, we review some important early developments on causal inference in medical statistics and epidemiology that were inspired by questions in oncology. We examine two classical examples from the literature and point to a current area of ongoing methodological development, namely the estimation of optimal adaptive treatment strategies. While causal approaches to analysis have become more routine in oncology research, many exciting challenges and open problems remain, particularly in the context of censored outcomes.

Open Access 20. Februar 2023

The EBM+ movement

Michael Wilde

Seiten: 283-293

Mehr PDF downloaden

Abstract

In this paper, I provide an introduction for biostatisticians and others to some recent work in the philosophy of medicine. Firstly, I give an overview of some philosophical arguments that are thought to create problems for a prominent approach towards establishing causal claims in medicine, namely, the Evidence-Based Medicine (EBM) approach. Secondly, I provide an overview of further recent work in the philosophy of medicine, which argues that mechanistic studies can help to address these problems. Lastly, I describe a novel approach for establishing causal claims in medicine that has been informed by this recent work in the philosophy of medicine, namely, the EBM+ approach.

Open Access 9. Dezember 2022

Bayesianism from a philosophical perspective and its application to medicine

Jon Williamson

Seiten: 295-307

Mehr PDF downloaden

Abstract

Bayesian philosophy and Bayesian statistics have diverged in recent years, because Bayesian philosophers have become more interested in philosophical problems other than the foundations of statistics and Bayesian statisticians have become less concerned with philosophical foundations. One way in which this divergence manifests itself is through the use of direct inference principles: Bayesian philosophers routinely advocate principles that require calibration of degrees of belief to available non-epistemic probabilities, while Bayesian statisticians rarely invoke such principles. As I explain, however, the standard Bayesian framework cannot coherently employ direct inference principles. Direct inference requires a shift towards a non-standard Bayesian framework, which further increases the gap between Bayesian philosophy and Bayesian statistics. This divergence does not preclude the application of Bayesian philosophical methods to real-world problems. Data consolidation is a key challenge for present-day systems medicine and other systems sciences. I show that data consolidation requires direct inference and that the non-standard Bayesian methods outlined here are well suited to this task.

17. Mai 2023

Bayesian inference for optimal dynamic treatment regimes in practice

Daniel Rodriguez Duque, Erica E. M. Moodie, David A. Stephens

Seiten: 309-331

Mehr

Abstract

In this work, we examine recently developed methods for Bayesian inference of optimal dynamic treatment regimes (DTRs). DTRs are a set of treatment decision rules aimed at tailoring patient care to patient-specific characteristics, thereby falling within the realm of precision medicine. In this field, researchers seek to tailor therapy with the intention of improving health outcomes; therefore, they are most interested in identifying optimal DTRs. Recent work has developed Bayesian methods for identifying optimal DTRs in a family indexed by ψ via Bayesian dynamic marginal structural models (MSMs) (Rodriguez Duque D, Stephens DA, Moodie EEM, Klein MB. Semiparametric Bayesian inference for dynamic treatment regimes via dynamic regime marginal structural models. Biostatistics; 2022. (In Press)); we review the proposed estimation procedure and illustrate its use via the new BayesDTR R package. Although methods in Rodriguez Duque D, Stephens DA, Moodie EEM, Klein MB. (Semiparametric Bayesian inference for dynamic treatment regimes via dynamic regime marginal structural models. Biostatistics; 2022. (In Press)) can estimate optimal DTRs well, they may lead to biased estimators when the model for the expected outcome if everyone in a population were to follow a given treatment strategy, known as a value function, is misspecified or when a grid search for the optimum is employed. We describe recent work that uses a Gaussian process ( G P ) $(\mathcal{G}\mathcal{P})$ prior on the value function as a means to robustly identify optimal DTRs (Rodriguez Duque D, Stephens DA, Moodie EEM. Estimation of optimal dynamic treatment regimes using Gaussian processes; 2022. Available from: https://doi.org/10.48550/arXiv.2105.12259). We demonstrate how a G P $\mathcal{G}\mathcal{P}$ approach may be implemented with the BayesDTR package and contrast it with other value-search approaches to identifying optimal DTRs. We use data from an HIV therapeutic trial in order to illustrate a standard analysis with these methods, using both the original observed trial data and an additional simulated component to showcase a longitudinal (two-stage DTR) analysis.

11. Juli 2023

Agent-based modeling in medical research, virtual baseline generator and change in patients’ profile issue

Philippe Saint-Pierre, Nicolas Savy

Seiten: 333-349

Mehr

Abstract

Simulation studies are promising in medical research in particular to improve drug development. For instance, one can aim to develop In Silico Clinical Trial in order to challenge trial’s design parameters in terms of feasibility and probability of success of the trial. Approaches based on agent-based models draw on a particularly useful framework to simulate patients evolution. In this paper, an approach based on agent-based modeling is described and discussed in the context of medical research. An R-vine copula model is used to represent the multivariate distribution of the data. A baseline data cohort can then be simulated and execution models can be developed to simulate the evolution of patients. R-vine copula models are very flexible tools which allow researchers to consider different marginal distributions than the ones observed in the data. It is then possible to perform data augmentation to explore a new population by simulating baseline data which are slightly different than those of the original population. A simulation study illustrates the efficiency of copula modeling to generate data according to specific marginal distributions but also highlights difficulties inherent to data augmentation.

3. Juli 2023

Agent based modeling in health care economics: examples in the field of thyroid cancer

Romain Demeulemeester, Nicolas Savy, Pascale Grosclaude, Nadège Costa, Philippe Saint-Pierre

Seiten: 351-368

Mehr

Abstract

Although they remain little used in the field of Health Care Economics, Agent Based Models (ABM) are potentially powerful decision-making tools that open up great prospects. The reasons for this lack of popularity are essentially to be found in a methodology that should be further clarified. This article hence aims to illustrate the methodology by means of two applications to medical examples. The first example of ABM illustrates the construction of a Baseline Data Cohort by means of a Virtual Baseline Generator. The aim is to describe the prevalence of thyroid cancer in the French population over the long term according to different scenarios of evolution of this population. The second study considers a setting where the Baseline Data Cohort is an established cohort of (real) patients: the EVATHYR cohort. The aim of the ABM is to describe the long-term costs associated with different scenarios of thyroid cancer management. The results are evaluated using several simulation runs in order to observe the variability of simulations and to derive prediction intervals. The ABM approach is very flexible since several sources of data can be involved and a large variety of simulation models can be calibrated to generate observations according to different evolution scenarios.

24. Oktober 2022

A copula-based set-variant association test for bivariate continuous, binary or mixed phenotypes

Julien St-Pierre, Karim Oualkacha

Seiten: 369-387

Mehr

Abstract

In genome wide association studies (GWAS), researchers are often dealing with dichotomous and non-normally distributed traits, or a mixture of discrete-continuous traits. However, most of the current region-based methods rely on multivariate linear mixed models (mvLMMs) and assume a multivariate normal distribution for the phenotypes of interest. Hence, these methods are not applicable to disease or non-normally distributed traits. Therefore, there is a need to develop unified and flexible methods to study association between a set of (possibly rare) genetic variants and non-normal multivariate phenotypes. Copulas are multivariate distribution functions with uniform margins on the [0, 1] interval and they provide suitable models to deal with non-normality of errors in multivariate association studies. We propose a novel unified and flexible copula-based multivariate association test (CBMAT) for discovering association between a genetic region and a bivariate continuous, binary or mixed phenotype. We also derive a data-driven analytic p -value procedure of the proposed region-based score-type test. Through simulation studies, we demonstrate that CBMAT has well controlled type I error rates and higher power to detect associations compared with other existing methods, for discrete and non-normally distributed traits. At last, we apply CBMAT to detect the association between two genes located on chromosome 11 and several lipid levels measured on 1477 subjects from the ASLPAC study.

24. Oktober 2022

Detection of atypical response trajectories in biomedical longitudinal databases

Lucio José Pantazis, Rafael Antonio García

Seiten: 389-415

Mehr

Abstract

Many health care professionals and institutions manage longitudinal databases, involving follow-ups for different patients over time. Longitudinal data frequently manifest additional complexities such as high variability, correlated measurements and missing data. Mixed effects models have been widely used to overcome these difficulties. This work proposes the use of linear mixed effects models as a tool that allows to search conceptually different types of anomalies in the data simultaneously.

3. November 2022

Potential application of elastic nets for shared polygenicity detection with adapted threshold selection

Majnu John, Todd Lencz

Seiten: 417-438

Mehr

Abstract

Current research suggests that hundreds to thousands of single nucleotide polymorphisms (SNPs) with small to modest effect sizes contribute to the genetic basis of many disorders, a phenomenon labeled as polygenicity. Additionally, many such disorders demonstrate polygenic overlap, in which risk alleles are shared at associated genetic loci. A simple strategy to detect polygenic overlap between two phenotypes is based on rank-ordering the univariate p -values from two genome-wide association studies (GWASs). Although high-dimensional variable selection strategies such as Lasso and elastic nets have been utilized in other GWAS analysis settings, they are yet to be utilized for detecting shared polygenicity. In this paper, we illustrate how elastic nets, with polygenic scores as the dependent variable and with appropriate adaptation in selecting the penalty parameter, may be utilized for detecting a subset of SNPs involved in shared polygenicity. We provide theory to better understand our approaches, and illustrate their utility using synthetic datasets. Results from extensive simulations are presented comparing the elastic net approaches with the rank ordering approach, in various scenarios. Results from simulations studies exhibit one of the elastic net approaches to be superior when the correlations among the SNPs are high. Finally, we apply the methods on two real datasets to illustrate further the capabilities, limitations and differences among the methods.

8. Mai 2023

Error analysis of the PacBio sequencing CCS reads

Reza Pourmohammadi, Jamshid Abouei, Alagan Anpalagan

Seiten: 439-453

Mehr

Abstract

Third generation sequencing technologies such as Pacific Biosciences and Oxford Nanopore provide faster, cost-effective and simpler assembly process generating longer reads than the ones in the next generation sequencing. However, the error rates of these long reads are higher than those of the short reads, resulting in an error correcting process before the assembly such as using the Circular Consensus Sequencing (CCS) reads in PacBio sequencing machines. In this paper, we propose a probabilistic model for the error occurrence along the CCS reads. We obtain the error probability of any arbitrary nucleotide as well as the base calling Phred quality score of the nucleotides along the CCS reads in terms of the number of sub-reads. Furthermore, we derive the error rate distribution of the reads in relation to the pass number. It follows the binomial distribution which can be approximated by the normal distribution for long reads. Finally, we evaluate our proposed model by comparing it with three real PacBio datasets, namely, Lambda, and E. coli genomes, and Alzheimer’s disease targeted experiment.

Open Access 27. Oktober 2022

A SIMEX approach for meta-analysis of diagnostic accuracy studies with attention to ROC curves

Annamaria Guolo, Tania Erika Pesantez Cabrera

Seiten: 455-471

Mehr PDF downloaden

Abstract

Bivariate random-effects models represent an established approach for meta-analysis of accuracy measures of a diagnostic test, which are typically given by sensitivity and specificity. A recent formulation of the classical model describes the test accuracy in terms of study-specific Receiver Operating Characteristics curves. In this way, the resulting summary curve can be thought of as an average of the study-specific Receiver Operating Characteristics curves. Within this framework, the paper shows that the standard likelihood approach for inference is prone to several issues. Small sample size can give rise to unreliable conclusions and convergence problems deeply affect the analysis. The proposed alternative is a simulation-extrapolation method, called SIMEX, developed within the measurement error literature. It suits the meta-analysis framework, as the accuracy measures provided by the studies are estimates rather than true values, and thus are prone to error. The methods are compared in a series of simulation studies, covering different scenarios of interest, including deviations from normality assumptions. SIMEX reveals a satisfactory strategy, providing more accurate inferential results if compared to the likelihood approach, while avoiding convergence failure. The approaches are applied to a meta-analysis of the accuracy of the ultrasound exam for diagnosing abdominal tuberculosis in HIV-positive subjects.

28. Oktober 2022

Statistical modelling of COVID-19 and drug data via an INAR(1) process with a recent thinning operator and cosine Poisson innovations

Zohreh Mohammadi, Hassan S. Bakouch, Maryam Sharafi

Seiten: 473-488

Mehr

Abstract

In this paper, we propose the first-order stationary integer-valued autoregressive process with the cosine Poisson innovation, based on the negative binomial thinning operator. It can be equi-dispersed, under-dispersed and over-dispersed. Therefore, it is flexible for modelling integer-valued time series. Some statistical properties of the process are derived. The parameters of the process are estimated by two methods of estimation and the performances of the estimators are evaluated via some simulation studies. Finally, we demonstrate the usefulness of the proposed model by modelling and analyzing some practical count time series data on the daily deaths of COVID-19 and the drug calls data.

24. November 2022

The balanced discrete triplet Lindley model and its INAR(1) extension: properties and COVID-19 applications

Masoumeh Shirozhan, Naushad A. Mamode Khan, Célestin C. Kokonendji

Seiten: 489-516

Mehr

Abstract

This paper proposes a new flexible discrete triplet Lindley model that is constructed from the balanced discretization principle of the extended Lindley distribution. This model has several appealing statistical properties in terms of providing exact and closed form moment expressions and handling all forms of dispersion. Due to these, this paper explores further the usage of the discrete triplet Lindley as an innovation distribution in the simple integer-valued autoregressive process (INAR(1)). This subsequently allows for the modeling of count time series observations. In this context, a novel INAR(1) process is developed under mixed Binomial and the Pegram thinning operators. The model parameters of the INAR(1) process are estimated using the conditional maximum likelihood and Yule-Walker approaches. Some Monte Carlo simulation experiments are executed to assess the consistency of the estimators under the two estimation approaches. Interestingly, the proposed INAR(1) process is applied to analyze the COVID-19 cases and death series of different countries where it yields reliable parameter estimates and suitable forecasts via the modified Sieve bootstrap technique. On the other side, the new INAR(1) with discrete triplet Lindley innovations competes comfortably with other established INAR(1)s in the literature.

Ahead-of-Print / Just-Accepted

Ahead-of-Print / Just-Accepted

Band 19 (2023)

Band 18 (2022)

Band 17 (2021)

Band 16 (2020)

Band 15 (2019)

Band 14 (2018)

Band 13 (2017)

Band 12 (2016)

Band 11 (2015)

Band 10 (2014)

Band 9 (2013)

Band 8 (2012)

Band 7 (2011)

Heft 1

Band 6 (2010)

Journal Impact Factor	1.2	2022, Journal Citation Reports (Clarivate, 2023)
5-year Journal Impact Factor	1.3	2022, Journal Citation Reports (Clarivate, 2023)
Journal Citation Indicator	0.48	2022, Journal Citation Reports (Clarivate, 2023)
CiteScore	2.1	2022, Scopus (Elsevier B.V., 2023)
SCImago Journal Rank	0.540	2022, SJR (Scimago Lab, 2023; Data Source: Scopus)
Source Normalized Impact per Paper	1.224	2022, CWTS Journal Indicators (CWTS B.V., 2023; Data Source: Scopus)
Mathematical Citation Quotient	0.17

Weitere Informationen über Zeitschriftenmetriken

Einreichen

Submission
Online Submission Tool

Your benefits of publishing with us

Rapid publication times
Thorough reviews
Optional open access publication
Accepted papers will be published online first as DOI-citable, forward-linked articles for quickest possible visibility for the scientific community
Every article easily discoverable because of Search Engine Optimization (SEO) and comprehensive abstracting and indexing services
Convenient citation tracking via e-mail alert
Secure archiving by De Gruyter and the independent archiving service Portico
Professional sales and marketing activities

Submission process

Submit your paper via our ScholarOne submission management tool following the Instruction for Authors
After logging in you will be guided through every step of the submission process
Peer review process
A decision on your paper made as soon as possible
Accepted articles are published online ahead of print first

Please note

For free online access to all articles, please register on our website. To access the articles, simply click on "Get access to full text" on any article you wish to view
Readers of the International Journal of Biostatistics have free access to International Journal of Biostatistics articles. To access the articles, simply click on "Get access to full text" on any article you wish to view
Manuscripts must be written in clear and concise English
Before submitting your article please have a look at our copyright agreement
Once your article is accepted you have the option to publish it open access
Our repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract
If you have any general questions please visit our FAQ page for authors

We look forward to receiving your manuscript!

Editorial

Editors-in-Chief
Antoine Chambaz, Université Paris Descartes
Alan Hubbard, University of California, Berkeley
Mark van der Laan, University of California, Berkeley

Founding Editors
Raymond Carroll, Texas A&M University
Nicholas Jewell, University of California, Berkeley
James Robins, Harvard University
Mark van der Laan, University of California, Berkeley

Editorial Board
Laura Balzer, University of Massachusetts, Amherst
Arne Bathke, University of Salzburg
David Benkeser, University of California, Berkeley
Olivier Bouaziz, Université Paris Descartes
Marco Carone, University of Washington
Magali Champion, Université de Paris
Kwun Chuen (Gary) Chan, Fred Hutchinson Cancer Research Center
Christophe Denis, Université Gustave Eiffel
Oliver Dukes, Universiteit Gent, University of Pennsylvania
Ashkan Ertefaie, University of Michigan
Alessio Farcomeni, University of Rome 'Tor Vergata'
Ernest Fokoue, Rochester Institute of Technology
Agathe Guilloux, Université d'Évry Val d'Essonne
Annamaria Guolo, Padua University
Nima Hejazi, Harvard T.H. Chan School of Public Health
Cheng Ju, Facebook Research
Jay Kaufman, McGill University
Edward Kennedy, Carnegie Mellon University
Adeline Leclercq Samson, Université Grenoble Alpes
Alex Luedtke, University of Washington
Miguel-Angel Luque, London School of Hygiene and Tropical Medicine
Andreas Mayr, University of Bonn
Ian McKeague, Columbia University
Nandita Mitra, University of Pennsylvania
Caleb Miles, Columbia University
Stephan Morgenthaler, L'Ecole Polytechnique Fédérale de Lausanne
Elizabeth Ogburn, Johns Hopkins University
Sarah Ouada, AgroParisTech, Université Paris-Saclay Équipe Stat & Génome
Christian Bressen Pipper, LEO Pharma
Robert Platt, McGill University
Eric Polley, Mayo Clinic
Mélanie Prague, Inria-INSERM-Université de Bordeaux
Michael Rosenblum, Johns Hopkins University
Laura Sangalli, Politecnico di Milano
Mireille Schnitzer, Université de Montréal
Mark Segal, University of California, San Francisco
Steve Shiboski, University of California, San Francisco
David A. Stephens, McGill University
Jianguo Sun, University of Missouri
Yanqing Sun, University of North Carolina at Charlotte
Linda Valeri, Columbia University Mailman School of Public Health
Vivian Viallon, WHO International Agency for Research on Cancer
Jingshen Wang, University of California, Berkeley
Julian Wolfson, University of Minnesota
Min Zhang, University of Michigan

(English)

Online ISSN: 1557-4679
Typ: Zeitschrift
Sprache: Englisch
Verlag: De Gruyter
Erstveröffentlichung: 1. Mai 2005
Erscheinungsweise: 2 Hefte pro Jahr
Zielgruppe: Researchers and practitioners interested in biostatistics